Investigating the mysteries of proteins considered undruggable to expand the druggable genome.

Robot healthcare assistants designed to operate in outer space may sound like science fiction, but the reality is incredibly feasible. In this Commentary article, Daniel Leidner explains how telerobotics-enabled hardware is currently being trialled in different laboratory environments as a means of providing remote healthcare.

We hear the opinions of organ modelling experts on navigating three concepts which are critical to the field: complexity, robustness, and reproducibility.

In this Insight article, we explore SiLA: the consortium for Standardisation in Lab Automation, and look at some of the opportunities and challenges presented in the vision for a fully integrated laboratory environment.

AstraZeneca have been using the technology to evaluate drug-induced nephrotoxic effects

Cell-based therapies are a rapidly growing area of research with great promise.

Drug discovery experts join Oxford Global’s Neuroscience Drug Discovery and Development discussion group.

For the first time since 1938, the FDA will no longer require animal modelling for drugs to enter clinical trials after a new Act is passed.

A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurement

The biggest focus for those in the pharmaceuticals industry moving forward should be to emphasise the importance of proactive adaptability in implementing FAIR data frameworks, and to underscore how making the investment now will pay dividends in years to come.

Oxford Global’s discussion group brings together specialists in target identification, phenotypic, and cell-based screening